MIRA

Mira Pharmaceuticals

Stock NASDAQ – Stock Market Prices, News & Analysis

Mira Pharmaceuticals Inc est une entreprise spécialisée dans la recherche et développement de médicaments innovants pour divers traitements médicaux.

$ 1.20
1.64 %

Mira Pharmaceuticals

$ 1.20
1.64 %
MIRA

Mira Pharmaceuticals Inc est une entreprise spécialisée dans la recherche et développement de médicaments innovants pour divers traitements médicaux.

Price history of Mira Pharmaceuticals
Price history of Mira Pharmaceuticals

Performance & Momentum

6 Months 19.86 %
1 Year 16.49 %
3 Years 84.77 %
5 Years 81.20 %
Momentum
79

Strategic Analysis

Mira Pharmaceuticals • 2026

Mira Pharmaceuticals Inc positions itself as a biotechnology company focused on the research and development of innovative medical treatments. Its differentiation is based on its expertise in pharmaceutical development, targeting therapeutic niches with significant potential for clinical disruption.

Strengths
  • Specialization in medical R&D, a potential source of disruptive growth
  • Presence in the American market, the primary area for pharmaceutical innovation
  • Ability to attract collaborations or funding in a sector with high barriers to entry
Weaknesses
  • History of very volatile financial performance over the long term
  • Lack of recent catalysts or favorable news to support the momentum
Momentum

After a prolonged decline over several years, the stock is showing a notable recovery over a more recent period, indicating a possible resurgence of investor interest. However, the absence of fresh news calls for increased vigilance, and the momentum remains fragile, relying on concrete clinical progress.

Analysis performed 6 days ago

Similar stocks to Mira Pharmaceuticals

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone